SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-030738
Filing Date
2023-03-09
Accepted
2023-03-09 21:11:33
Documents
2
Period of Report
2023-03-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm238905-15_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm238905-15_3seq1.xml 3 1597
2 EXHIBIT 24.1 tm238905d15_ex24-1.htm EX-24.1 7478
  Complete submission text file 0001104659-23-030738.txt   10693
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARISMA THERAPEUTICS INC. 3675 MARKET STREET, SUITE 200 PHILADELPHIA PA 19104
Business Address
Torok Michael (Reporting) CIK: 0001967237 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 23721425